ULUSLARARASI BİLDİRİLER
1) Neuropsychological assessment and ERP evaluation of non-demented sporadic ALS patients compared with healthy controls. HA. Hanağası, İH Gürvit, G. Kaptanoğlu, N. Ermutlu, S. Karamürsel, HA. İdrisoğlu. 8th. International Symposium on ALS/MND, Abstract Booklet, Glasgow-1997.
2) Motor neuron disease and frontal lobe dementia: A report of three cases. İ. H. Gürvit, E. Tüzün, HA. Hanağası, G. Kaptanoğlu and H. A. İdrisoğlu. XVI World Congress of Neurology Buenos Aires, Argentina, Journal of the Neurological Sciences 1997;150(Supplement1):153.
3) Event-related brain potentials in Amyotrophic Lateral Sclerosis patients. N. Ermutlu, HA. Hanağası, G. Kaptanoğlu, S. Karamürsel, İH Gürvit, HA. İdrisoğlu, M. Emre, T. Demiralp. 9th World, Congress of the International Organization of Psychophysiology Sicily-1998. International Journal Of Psychology 1998;30(1-2):160-161.
4) Celiac disease and Neurologic Involvement: A case report. HA. Hanağası, H Şahin, E Gürol, M. Emre.13. International Congress on Parkinson Disease. Vancouver-1999. Parkinsonism&Related Disorders 1999;5(supl):122.
5) Stiff Leg Syndrome- A focal form of Stiff Man Syndrome? HA. Hanağası, E. Gürol, HA. Şahin, M. Emre.13. International Congress on Parkinson Disease. Vancouver-1999. Parkinsonism&Related Disorders 1999;5(supl):122.
6) Neuronal intranuclear inclusions in juvenile parkinsonism. JD. O’Sullivan, HA. Hanağası, SE. Daniel, AJ. Lees.13. International Congress on Parkinson Disease. Vancouver-1999. Parkinsonism&Related Disorders 1999;5(supl):24.
7) Familial Creutzfeldt-Jakob disease in Turkey: Characterization of the Codon 178 Asp-Asn mutation in a large Turkish kindred. M. Ozansoy, T. Campbell, N. Ersoy, D. Craufurd, A. Dodge, A. Boyacıyan, I. Baral, N. Erbeş, HA. Hanağası, G. Kaptanoğlu, İH. Gürvit, M. Emre, J Collinge, AN. Başak. 31st Annual Meeting of the European Society of Human Genetics Geneva-Switzerland -1999. European Journal of human Genetics 1999:7 (supl 1):124
8) Clozapine treatment in oromandibular dystonia. HA. Hanağası. 6th International Congress of Parkinson’s Disease and Movement Disorders. Barcelona-2000. Movement Disorders. 2000;15 (supl. 3):138-139.
9) Unilateral ablative lesions of the subthalamic nucleus in advanced Parkinson’s disease. HA. Hanağası, O. Barlas, HA. Şahin, M. İmer, M. Emre. 14. International Congress on Parkinson Disease. Helsinki-2001. Parkinsonism&Related Disorders 2001;5(supl):122.
10) Behavioral and psychological symptoms of Alzheimer’s disease in Turkey. S. Çakır, H. Gürvit, IB. Kulaksızoğlu, HA. Hanağası, H. Şahin, M. Emre. 10th. Congress of the International Psychogeriatric Association. International Psychogeriatrics 2001;13(Suppl 2):212.
11) Huntington’s disease in Turkey: The first report on molecular testing. N. Ersoy, B. Baboğlu, HA. Hanağası, S. Kızkın, AN. Başak. 19th International meeting of the world federation of neurology research group on Huntington’s disease. Abstract booklet 2001:37-38.
12) Treatment of writer’s cramp with botulinum toxin. Evaluation of 11 patients. HA. Hanağası, Y. Parman, HA. Şahin, H. Gürvit, J. Yazıcı, M. Emre. International Conference 2002, Basic and Therapeutic aspects of botulinum and tetanus toxins Hannover-2002. Naunyn-Schmiedeberg’s Archieves of Pharmacology 2002:365 (supp2):23.
13) Mitochondrial complex II/III and complex IV activities in familial and sporadic Parkinson’s disease.HA. Hanağası, D. Ayribas, K. Baysal, M. Emre. 7th International Congress of Parkinson’s Disease and Movement Disorders. Miami-2002. Movement Disorders. 2002;17 (supl. 5):150.
14) Community study of geriatric depression in Turkey: Prevalance and sociodemographic correlates. IB. Kulaksızoğlu, A. Polat, H. Harmancı, HA. Hanağası, B.Bilgic, H. Gürvit, M.Emre. American Association for Geriatric Psychiatry 16th Annual Meeting Honolulu-2003. Abstract booklet 2003:374-375.
15) Clinical and magnetic resonance imaging findings of HIV-negative syphilis patients. B. Bilgic, C. Gurses, B. Topcu, N. Yesilot, M. Kurtuncu, HA. Hanağası, H. Sahin, G. Akman-Demir, H. Gurvit, O. Coban, M. Emre. 13th Meeting of the European Neurological Society. Journal of Neurology 2003;250 (Supl. 2):166.
16) The attitude of Turkish elderly towards the symptoms of dementia. H. Gurvit, H. Sahin, B. Bilgic, E. Gurol, HA. Hanagasi, S. Tınaz, H. Harmancı, M. Emre. 19th International Conference of Alzheimer’s Disease International.
17) The prevalance of Alzheimer type dementia in a Turkish urban population. H. Gurvit, B. Bilgic, HA. Hanagasi, H. Sahin, S. Tınaz, E. Gurol, H. Harmancı, M. Emre. 19th International Conference of Alzheimer’s Disease International.
18) Mitochondrial complex I activity in familial and sporadic Parkinson’s disease.HA.Hanagasi, D. Ayribaş, K. Baysal. M. Emre. 8th International Congress of Parkinson’s Disease and Movement Disorders. Roma-2004. Movement Disorders. 2004;19 (supl. 9):148.
19) Polymorphisms of the DNA repair gene XRCC1 and Alzheimer’s disease. S. Dogru-Abbasoğlu, HA. Hanağası, N. Başak, M. Emre. M. Uysal, G. Aykaç-Toker. 29th meeting of the federation of the European biochemical societies. European Journal of Biochemistry 2004;271(Supl.1): 11-12.
20) Presenilin-1 gene intronic polymorphism in late-onset Alzheimer’s disease. E. Dursun, D. Gezen-Ak, E. Eker, T. Ertan, F. Engin, HA. Hanağası, H. Gürvit, M. Emre, S. Yılmazer. 9th International Alzheimer’s disease and related disorders. Philadelphia-2004. Neurobiology of Aging 2004;25 (Supl.2):511.
21) Target P3b potentials in the novelty paradigm are more sensitive than oddball P3b potentials in detecting cognitive impairment in early stage Alzheimer’s Disease (AD). B. Eryasar, B. Bilgic, HA. Hanagasi, U. Aydin, M. Emre, T. Demiralp. XIV. The Evoked Potentials International Conference Leipzig-2004. Abstract booklet 2004:67.
22) Pain in Parkinson’s disease. HA. Hanagasi, S. Akat, H. Gurvit, M. Emre, J. Yazici. 9h International Congress of Parkinson’s disease and Movement Disorders. New Orleans-2005. Movement Disorders. 2005;20 (supl. 10):99.
23) Polymorphisms at the ligand binding site of the vitamin D receptor gene and Alzheimer’s disease. D. Gezen-Ak, E. Dursun, T. Ertan, HA. Hanağası, H. Gürvit, M. Emre, E. Eker, M. Ozturk, F. Engin, S. Yılmazer. 21th International Conference of Alzheimer’s Disease International. Istanbul- Turkey. Abstract booklet 2005:50.
24) A novel presenilin 1 mutation (ALA396THR) is associated with early-onset Alzheimer’s disease. HA. Hanağası, FS. Hocaoğlu, B. Yokeş, H. Gürvit, M. Emre, AN. Başak. 21th International Conference of Alzheimer’s Disease International. Istanbul- Turkey. Abstract booklet 2005:52.
25) Validation study of the Turkish Translation of the neuropsychiatric inventory (NPI). ŞA. Kalem, HA. Hanağası, JL. Cummings, H. Gürvit. 21th International Conference of Alzheimer’s Disease International. Istanbul- Turkey. Abstract booklet 2005:58.
26) Validation study of the Turkish Translation of the frontal behavioural inventory (FBI). ŞA. Kalem, HA. Hanağası, A. Kertesz, H. Gürvit. 21th International Conference of Alzheimer’s Disease International. Istanbul- Turkey. Abstract booklet 2005:58.
27) Abundant COX (-) fibers in muscle of a patient with a novel parkin mutaion. H.A Hanağası, P. Serdaroğlu, M. Ozansoy, H. Gurvit, J. Yazici, N. Basak, M. Emre. 14 International Congress on Parkinson Disease. Berlin-2005. Parkinsonism&Related Disorders 2005;11(supl 2):185.
28) Time-frequency analysis of event-related potentials (ERPS) in mild Alzheimer disease (AD). Z. Bayraktaroğlu, B. Eryaşar, B. Bilgiç, HA. Hanağası, H. Gürvit, M. Emre, T. Demiralp. 9. International Conference on cognitive neuroscience. Havana-2005. Scientifitic Programs & Abstracts Book 2005:316.
29) The ERP characteristics of early Alzheimer’s disease. H. Gürvit, B. Eryaşar, Z. Bayraktaroğlu, B. Bilgiç, HA. Hanağası, M. Emre, T. Demiralp. 9. International Conference on cognitive neuroscience. Havana-2005. Scientifitic Programs & Abstracts Book 2005:312.
30) Neurosyphilis presenting status epilepticus: Two HIV (-) patients with EEG features. C. Gurses, M. Kurtuncu, N. Yesilot, HA. Hanağası, N. Bebek, B. Baykan, M. Emre, A. Gokyigit. 18th World Congress of Neurology, Sydney-2005. Journal of the neurological sciences 2005; 238 (Supll. 1): 124.
31) SNPS at the ligand binding site of the vitamin D receptor gene and Alzheimer’s disease. D. Gezen-Ak, E. Dursun, T. Ertan, HA. Hanağası, H. Gürvit, M. Emre, E. Eker, M. Ozturk, F. Engin, S. Yılmazer. 10th International Alzheimer’s disease and related disorders. Madrid-2006. Alzheimer’s&Dementia 2006;3 (Suppll. 1): 195-96.
32) Event-related oscillations in mesial temporal sclerosis and Alzheimer’s disease. H. Gürvit, Z. Bayraktaroğlu, HA. Hanağası, F. Hanağası, A. Gökyiğit, T. Demiralp. 13th World Congress of Psychophysiology. International Journal of Psychophysiology 2006;61:299-300.
33) Parkin immunolocalization in target fibers. S. Yilmazer, H. Tasli, HA. Hanağası, M. Emre, P. Serdaroglu. XIth International Congress on Neuromuscular Diseases İstanbul-2006. Neuromusculer Disorders 2006;16 (supl 1): 79.
34) Efficiency of botulinum toxin in treatment of writer’s cramp: Long-term follow-up results. Z. Matur, HA. Hanağası, Y. Parman. 11th International Congress of Parkinson’s disease and Movement Disorders. İstanbul-2007. Movement Disorders 2007;22 (supl. 16): 41.
35) Retrospective cross-over evaluation of two botulinum toxin type A preparations (Botox® and Dysport®) in the treatment of upper limb spasticity. Y. Parman, HA. Hanağası, B. Topcular. 11th International Congress of Parkinson’s disease and Movement Disorders. İstanbul-2007. Movement Disorders 2007;22 (supl. 16): 277.
36) Retrospective cross-over evaluation of two botulinum toxin type A preparations (Botox® and Dysport®) in the treatment of lower limb spasticity. Y. Parman, HA. Hanağası, B. Topcular. 11th International Congress of Parkinson’s Disease and Movement Disorders. İstanbul-2007. Movement Disorders 2007;22 (supl. 16): 279.
37) Clinical aspects of L-2-HGA disease in 13 Turkish children. Z. Yapıcı, K. Alpay, D. Yalçın, HA. Hanağası, M. Eraksoy. 17th Meeting of the European Neurological Society. J. Neurol 2007; 254(Suppl 3):97-98.
38) Event-related oscillations in Alzheimer’s disease. H. Gürvit, HA. Hanağası, Z. Bayraktaroğlu, M.Emre, T. Demiralp. 23th International Conference of Alzheimer’s Disease International. Caracas-Venezuela. Abstract booklet 2007:53.
39) Comparison of unilateral pallidotomy versus subthalamotomy in advanced idiopathic Parkinson’s disease. HA. Hanağası, A. Çoban, S. Bilgiç, H. Gürvit, J. Yazıcı, O. Barlas, M. Emre. 17. WFN World Congress on Parkinson’s Disease and Related Disorders. Parkinsonism&Related Disorders 2007;13(supl ):172-173.
40) Ataxia with vitamin E deficiency in Turkey. HA. Hanagasi, B. Castellotti, C. Mariotti, C. Gellera, H. Gürvit, J. Yazici, M. Emre. 12th International Congress of Parkinson’s Disease and Movement Disorders. Şikago-2008. Movement Disorders 2008;22 (supl. 1): 456.
41) Polymorphisms in the DNA repair genes, Hogg1 and Ape1 and the risk of Alzheimer’s disease. H. Parıldar-Karpuzoğlu, S. Doğru-Abbasoğlu, HA. Hanagasi, B. Karadağ, H.Gürvit, M. Emre, M. Uysal. International Congress on Alzheimer’s Disease. Şikago-2008. Alzheimer’s&Dementia 2008:4 (supl. 2): 587.
42) Anti-neuronal antibodies in Hashimato’s thyroiditis patients with central nervous system involvement. H. Durmus, S. İçöz, E. Tüzün, M. Kürtüncü, HA. Hanağası, N. Bebek, B. Baykan, G. Akman-Demir, M. Eraksoy. 18. Meeting of the European Neurological Society Nice-2008. J Neurol 2008:255(Suppl 2): 139.
43) Polymorphisms in TNF-alpha (-308), IL-6 (-174) and IL-10 (-1082) genes and the risk for sporadic late-onset Alzheimer’s disease. P. Vural, S. Degirmencioglu, H. Parıldar-Karpuzoğlu, S. Doğru-Abbasoğlu, HA. Hanağası, B. Karadağ, H.Gürvit, M. Emre, M. Uysal. 3th International Congress of Molecular Medicine İstanbul-2009. IUBMB Life 2009;61:377
44) LRRK2 Exon 41 mutations are not common in Turkey. HA. Hanağası, E. Lohmann, B. Dursun, A. Honoré, S. Lesage, Ö. Aydın, G. Babacan, H. Gürvit, J. Yazıcı, N. Unaltuna-Erginel, A. Brice, M. Emre. 13th International Congress of Parkinson’s Disease and Movement Disorders. Paris-2009. Movement Disorders 2009;22 (supl. 1): 141.
45) Autosomal-recessive gene mutation frequencies in Turkish patients with Parkinson’s disease. B. Dursun, E. Lohmann, S. Lesage, HA. Hanağası, Ö. Aydın, G. Babacan, H. Gürvit, J. Yazıcı, N. Unaltuna-Erginel, M. Emre, A. Brice. 13th International Congress of Parkinson’s Disease and Movement Disorders Paris-2009. Movement Disorders 2009;22 (supl. 1): 137-138.
46) Extrapontine myelinolysis after correction of hyponatremia presenting as acute parkinsonism.HA. Hanağası, D. Aygün, F. Tufan, G. Babacan, H. Gürvit, J. Yazıcı, M. Emre. 18. WFN World Congress on Parkinson’s Disease and Related Disorders Miami, 2009. Parkinsonism&Related Disorders 2009;15(supl 2):107-108.
47) Botulinum toxin injections on the facial region. Z. Matur, A. Çoban, G. Babacan, E. Shugaiv, HA. Hanağası, Y. Parman. 20. meeting of the European Neuological Society Berlin, 2010.Journal of Neurology 2010; 257(supl 1):230.
48) An observational study in naturalistic setting on th efficacy of memantine on behavioral symptoms od Alzheimer’s Disease. H. Gürvit, IB. Kulaksızoğlu, M. Emre, G. Babacan, HA. Hanağası, EDSE Study Group. 10. International Confrence of Alzheimer Disease Hawai, 2010. Alzheimer’s & Dementia 2010; 6(supl 1):310.
49) Event-related potentials and oscillations during oddball task in Parkinson patients with PARK2 gene mutations. A. Uslu, T. Demiralp, M. Ergen, H. Demirci, HA. Hanağası. ECNS İstanbul 2010. Abstract booklet: 46.
50) TP53 R72P polymorphism as a modifier of age at onset of Huntington’s disease. NE. Tunali, A. Acar-Hazer, N. Erginel-Unaltuna, HA. Hanağası. EHDN Plenary Meeting Prag-2010. J Neurol Neurosurg Psychiatry 2010;81:A17
51) The effects of GRIN gene variations on age at onset of Turkish Huntington’s disease patients. NE. Tunali, A. Acar-Hazer, N Erginel-Unaltuna, HA. Hanağası. EHDN Plenary Meeting Prag-2010. J Neurol Neurosurg Psychiatry 2010;81:A17.
52) The effects of rasagiline on cognitive deficits in Parkinson’s Disease patients without dementia: A randomized, double-blind, placebo-controlled, multi-center study over 3 months. HA. Hanağası, IH. Gürvit, P. Unsalan, H. Horozoglu, N. Tuncer, A. Feyzioglu, DI. Gunal, R. Cakmur, GG Yener, HA. Sahin, M. Emre. 15th International Congress of Parkinson’s Disease and Movement Disorders. Toronto-2011. Movement Disorders 2011;26 (supl. 2): 280.
53) Frontal white matter hyperintensities correlate with depresive symptoms and functionality in mild Alzheimer’s disease. B. Bilgic, A. Bayram, H. Alpsan, A. Tumac, HA. Hanağası, H. Şahin, E. Lohmann, M. Emre, H. Gürvit. 11. International Confrence of Alzheimer Disease Paris, 2011. Alzheimer’s & Dementia 2011; 7(supl 1):728.
54) The effect of memantine on neuropsychiatric inventory (NPI) parallels with the reduction of caregiver burden: An analysis of an observational study in naturalistic setting. IB. Kulaksızoğlu, H. Gürvit, G. Babacan, HA. Hanağası, H. Şahin, M. Emre. 11. International Confrence of Alzheimer Disease Paris, 2011. Alzheimer’s & Dementia 2011; 7(supl 1):766.
55) Comparative analysis of event-related potentials and oscillations during auditory oddball task in Parkinson’s patients with Parkin gene mutations and idiopathic Parkinson’s disease. A. Uslu, M. Ergen, H. Demirci, HA. Hanağası, T. Demiralp. XIth International Conference on Cognitive Neuroscience (ICON XI), September 25-29, 2011. Palma, Mallorca, Spain. Abstract booklet: A140.
56) MDS-UPDRS dopamine dysregulation syndrome scores correlate with Iowa gambling test performance. H. Gurvit, N. Pulur, AD. Tatlidede, E. Yildirim,B. Bilgic, R. Cakmur, R HA. Hanağası. 19th International Congress of Parkinson’s Disease and Movement Disorders. Sydney-2013. Movement Disorders 2013; 28 Supplement: 1: 118.
57) Improvement under donepezil treatment in a patient with pure akinesia with freezing of gait. B. Topcular, A. Yabalak, A. Kaymaz, A. Altinkaya, NS. Topcular, B. Altunrende, E. Altindag, GA. Demir, HA.Hanağası, M. Emre. 19th International Congress of Parkinson’s Disease and Movement Disorders. Sydney-2013. Movement Disorders 2013; 28 Supplement: 1: 297-298.
58) Prevalence of Parkinson’s disease in Baskale, Turkey: A population-based study. H. Durmus, MA. Gokalp, HA. Hanağası. 19th International Congress of Parkinson’s Disease and Movement Disorders. Sydney-2013. Movement Disorders 2013; 28 Supplement: 1: 384-385.
59) FBXO7 mutation: Phenotypic variability from chorea to early-onset asymmetric parkinsonism within a family. A. Gunduz, AG. Eken, A. Gundogdu, K. Bilguvar, M. Gunel, AN. Basak, HA. Hanağası. S. Ertan. 19th International Congress of Parkinson’s Disease and Movement Disorders. Sydney-2013. Movement Disorders 2013; 28 Supplement: 1: 317-318.
60) Serum complement factor H levels in late onset Alzheimer’s disease. S. Yilmazer, D.Gezen-Ak, E. Dursun, HA. Hanağası, B. Bilgic, E. Lohhman, OS.Araz, I. Atasoy, M. Alaylioglu, B. Onal, H. Gurvit. 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) Saint Petersburg, Russia-2013. FEBS JOURNAL 2013; 280; SI: 430.
61) Neural correlates of lack of iInsight in mild cognitive impairment and Alzheimer’s disease. B. Bilgic, G. Senturk, HA. Hanağası, H. Gurvit, M. Emre. 13. International Confrence of Alzheimer Disease Boston, 2013. Alzheimer’s&Dementia 2013;4 (Supp 2):587.
62) Homozygous TREM2 Mutations another addition to the list of genetic causes of familial fontotemporal dementia. H. Gurvit, B. Bilgic, HA. Hanağası, R.Guerreiro, J.Hardy. 13. International Confrence of Alzheimer Disease Boston, 2013. Alzheimer’s&Dementia 2013;4 (Supp 2):860.
63) Non-Paraneoplastic limbic encephalitis associated with glutamic acid decarboxylase antibody. HA. Hanağası, B. Bilgic, U. Cikrikcili, C. Ulusoy, S. Turan, B. Baykan, E. Tüzün, M. Emre, H. Gurvit. 13. International Confrence of Alzheimer Disease Boston, 2013. Alzheimer’s&Dementia 2013;4 (Supp 2):731.
64) Serum TNF alpha Levels elevated in early and late onset Alzheimer’s disease but not in mild cogntive impairment. M. Alaylioglu, D. Gezen-Ak, E. Dursun, HA. Hanağası, B. Bilgic¸ E. Lohmann, OS. Araz, IL. Atasoy, B. Onal, H. Gurvit, S. Yilmazer.
65) Association between vitamin D binding protein (VDBP) haplotype and late-onset Alzheimer’s disease. OS. Araz, E. Dursun, D. Gezen-Ak, HA. Hanağası, B. Bilgic¸ E. Lohmann, T. Ertan, H. Gurvit, E. Eker, M. Emre, S. Yilmazer. 13. International Confrence of Alzheimer Disease Boston, 2013. Alzheimer’s&Dementia 2013;4 (Supp 2):177.
66) Neuropsychological evaulation and cortical thickness analysis of anasognosia in mild cognitive impairment and Alzheimer’s’disease. G. Senturk, B. Bilgic, C. Kenar, HA. Hanağası, H. Gurvit, M. Emre. 13. International Confrence of Alzheimer Disease Boston, 2013. Alzheimer’s&Dementia 2013;4 (Supp 2):592.
67) Botulinum toxin type-A injections for oromandibular dystonia. Z. Tufekcioglu, Z. Matur, HA. Hanağası, Y. Parman. Joint Congress of European Neurology, Istanbul, 2014. European Journal of Neurology 201;21 (Suppl. 1):450.
68) The distinct genetic pattern of ALS in Turkey. A. Özoğuz, Ö. Uyan, G. Birdal, C. Iskender, Ö. Ömür, S. Lahut, Z.S. Agim, E. Kartal, Y. Parman, E. Tan, F. Koç, F. Deymeer, P. Oflazer, HA. Hanağası, H. Gürvit, B. Bilgiç, H. Durmuş, M. Ertaş, D. Kotan, M.A. Akalın, H. Güllüoğlu, M. Zarifoğlu, F. Aysal, N. Döşoğlu, K. Bilguvar, M. Günel, Ö. Keskin, T. Akgün, H. Özçelik, A.N. Başak. Joint Congress of European Neurology, Istanbul, 2014. European Journal of Neurology 201;21 (Suppl. 1):63.
69) Neuroacanthocytosis: A case report. R. Yiğiter, MA. Elçi, HA. Hanağası. 20th International Congress of Parkinson’s Disease and Movement Disorders. Stockholm-2014. Movement Disorders. 2014; 29 (Suppl. 1):529
70) Testing of diagnostic criteria for mild cognitive impairment in patients with Parkinson’s disease.HA. Hanağası, P. Uysal-Canturk, B. Bilgic, H. Gurvit, M. Emre. 20th International Congress of Parkinson’s Disease and Movement Disorders. Stockholm-2014. Movement Disorders. 2014; 29 (Suppl. 1):934.
71) Neuroimaging findings of Nasu-Hakola disease. B. Bilgiç, Ö. Gelişin, R. Guerreiro, E. Lohmann, HA. Hanağası, H. Gürvit, M. Emre. 14. Alzheimer’s Association International Conference Copenhagen 2014, P1-287.
72) Evaluation of Incidence and Clinical Features of Antibody-Associated Autoimmune Encephalitis Mimicking Dementia. E. Erdag, A. Çoban, Cİ. Küçükali, B. Bilgiç, HA. Hanağası, H. Gürvit, E. Tüzün. 14. Alzheimer’s Association International Conference Copenhagen 2014, P1-165.
73) MOCA, MMSE and ACE-R for the assessment of Mild Cognitive Impairment in patients with Parkinson’s Disease. HA. Hanağası, P. Uysal-Cantürk, B. Bilgiç, H. Gürvit, M. Emre. 14. Alzheimer’s Association International Conference Copenhagen 2014, P1-343
74) Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation. HA. Hanağası, B. Bilgic, T.E.M. Abbink, Figen Hanagasi, Z. Tüfekçioglu, N. Başak, M.S. van der Knaap, M. Emre. 21th International Congress of Parkinson’s Disease and Movement Disorders. San Diego-2015 Movement Disorders 2015;Supp 1:1165
75) Adult onset phenylketonuria with rapidly progressive dementia and parkinsonism. Z. Tufekcioglu, A. Cakar, B. Bilgic, HA. Hanagasi, H. Gurvit, M. Emre. 21th International Congress of Parkinson’s Disease and Movement Disorders. San Diego-2015. Movement Disorders 2015;Supp 1:1237